These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9716368)

  • 21. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute depletion of serotonin down-regulates serotonin transporter mRNA in raphe neurons.
    Yu A; Yang J; Pawlyk AC; Tejani-Butt SM
    Brain Res; 1995 Aug; 688(1-2):209-12. PubMed ID: 8542310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
    J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
    Rueter LE; De Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.
    David DJ; Froger N; Guiard B; Przybylski C; Jego G; Boni C; Hunt SP; De Felipe C; Hamon M; Jacquot C; Gardier AM; Lanfumey L
    Eur J Pharmacol; 2004 May; 492(1):41-8. PubMed ID: 15145704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
    Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
    Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung C; Fritzemeier KH; Fink G
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):119-28. PubMed ID: 10581405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infraorbital nerve transection alters serotonin transporter expression in sensory pathways in early postnatal rat development.
    Hansson SR; Cabrera-Vera TM; Hoffman BJ
    Brain Res Dev Brain Res; 1998 Dec; 111(2):305-14. PubMed ID: 9838174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer.
    Fabre V; Boutrel B; Hanoun N; Lanfumey L; Fattaccini CM; Demeneix B; Adrien J; Hamon M; Martres MP
    J Neurosci; 2000 Jul; 20(13):5065-75. PubMed ID: 10864964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
    Duncan MJ; Hensler JG
    Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system.
    Volle J; Bregman T; Scott B; Diwan M; Raymond R; Fletcher PJ; Nobrega JN; Hamani C
    Neuropharmacology; 2018 Jun; 135():63-72. PubMed ID: 29505786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies.
    Cabrera-Vera TM; Battaglia G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1474-81. PubMed ID: 9732413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.
    Li Q; Wichems C; Heils A; Lesch KP; Murphy DL
    J Neurosci; 2000 Nov; 20(21):7888-95. PubMed ID: 11050108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
    Rueter LE; Kasamo K; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.